Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine

Carrie E Robertson, Ivan GarzaDepartment of Neurology, Mayo Clinic, Rochester, MN, USAAbstract: OnabotulinumtoxinA, a neurotoxin, has been studied in numerous trials as a novel preventive therapy for migraine headache. The data would support that it may be effective at reducing headache days in pati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robertson CE, Garza I
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/d61c8e60befc41f7829af236dcaf6094
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares